Babylon SPAC Presentation Deck
Consolidated Statement of Profit and Loss
For the Years Ended December 31,
$ in thousands
Revenue
1 Cost of Care Delivery
2 R&D and Technology Expenses
3 Sales, General & Administration Expenses
Operating Loss
Net Finance Costs
Exchange Rate Gains/ (Losses)(1)
Share of Loss of Equity-accounted
Investees
Loss Before Taxation
Tax Benefit/ (Provision)
Net Loss
2019A
16,034
(19,810)
(68,153)
(90,891)
(162,820)
(101)
17,075
(145,846)
5,559
(140,287)
2020A
79,272
(67,254)
(84,188)
(175,511)
(103,341) 2 Employee-related expenses (salaries, bonuses, stock-based compensation
expense, training expenses and benefits for employees and contractors in our
technology department); includes tax credits relating to our R&D activities and the
amortization of capitalized development costs; largely fixed expense base growing
commensurate with ongoing maintenance and continued development
(3,920)
(2,836)
(1,124)
(183,391)
(4,639)
(188,030)
Primary Drivers
1 Fees paid to providers/health professionals plus costs incurred in connection with
provider network operations; recorded as an expense when VBC revenue is
recognized - largely variable driven by member activity and required medical
services
3 Employee-related expenses, contractors and consultants' expense, stock-based
compensation, property and facility related expenses, IT and hosting, marketing,
training and recruiting expenses; includes depreciation of property, fixtures and
fittings and amortization of acquired intangible assets; largely fixed expense base
with expense growth associated with incremental costs as a new public company
and other business growth related expense
Source: Management reporting. Note:
1) Gain includes those resulting from inter-company relationships with significant GBP balances within USD companies translated at rates in accordance with IFRS.
92View entire presentation